A Study to Check the Safety of Dexlansoprazole and Learn if it Can Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Children 2 to 11 Years Old

NCT02616302 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
70
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Takeda